Skip to main content
Indo US Bio-Tech Limited logo

Indo US Bio-Tech Limited — Investor Relations & Filings

Ticker · INDOUS ISIN · INE250Z01010 LEI · 335800C8LDCWCED9W826 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 110 across all filing types
Latest filing 2024-10-01 Regulatory Filings
Country IN India
Listing BSE.NS INDOUS

About Indo US Bio-Tech Limited

https://indousagriseeds.com/

Indo US Bio-Tech Limited specializes in the research, development, and production of high-quality hybrid seeds. The company focuses on creating genetically superior seeds for a wide range of crops, including vegetables, oilseeds, pulses, and cereals. Key products include hybrid varieties of tomato, chili, okra, castor, and maize. The organization emphasizes agricultural innovation through its dedicated research and development facilities, aiming to enhance crop yields, improve disease resistance, and ensure climate adaptability. By leveraging advanced biotechnological techniques, the company provides sustainable solutions and high-performance seeds tailored to diverse agro-climatic conditions.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2024-10-01 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed account of the proceedings of the 20th Annual General Meeting (AGM) of Indo Us Bio Tech Limited held on September 30, 2024. It includes information about the meeting's conduct, attendees, voting procedures, and closing remarks. There is no financial data or report content, but rather a formal summary of the AGM event itself. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or the proceedings of the AGM. The document is over 5,000 characters and is not merely an announcement or notice, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is AGM-R with high confidence.
2024-09-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed summary of the proceedings of the 20th Annual General Meeting (AGM) of Indo Us Bio-Tech Limited held on September 30, 2024. It includes information about the meeting's conduct, attendance, agenda items, voting procedures, and resolutions passed. The document is not the full Annual Report or financial statements but rather a report on the AGM event itself. It specifically mentions the outcome of the AGM and the process of voting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The length of the document (6251 characters) and the content confirm it is a meeting outcome report rather than a brief announcement or a full report like a 10-K or IR. Therefore, the appropriate classification is DVA with high confidence.
2024-09-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter and half year ending September 30, 2024. It references the upcoming unaudited financial results but does not contain any financial data or the results themselves. The document is a regulatory compliance announcement related to insider trading restrictions, not the financial report or earnings release itself. Given the short length (1597 characters) and the nature of the content, this fits best under Regulatory Filings (RNS) as a general compliance announcement rather than an Earnings Release (ER) or Interim Report (IR).
2024-09-27 English
General Updates
Regulatory Filings
2024-09-27 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.